Показ 1 - 5 результатів із 5 для пошуку 'Vibhuti Vyas (15055988)', час виконання запиту: 0.02сек. Уточнити результати
  1. 1
    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... за авторством Ibrahim Aldoss (15055961)

    Опубліковано 2025
    Інші автори:
    Додати у Вибране
    Збережено в:
  2. 2
    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... за авторством Ibrahim Aldoss (15055961)

    Опубліковано 2025
    Інші автори:
    Додати у Вибране
    Збережено в:
  3. 3
    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... за авторством Ibrahim Aldoss (15055961)

    Опубліковано 2025
    Інші автори:
    Додати у Вибране
    Збережено в:
  4. 4
    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... за авторством Ibrahim Aldoss (15055961)

    Опубліковано 2025
    Інші автори:
    Додати у Вибране
    Збережено в:
  5. 5
    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... за авторством Ibrahim Aldoss (15055961)

    Опубліковано 2025
    Інші автори:
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: